Safety of Sports for Patients With a Subcutaneous Implantable Cardioverter Defibrillator
SPORT-SICD
1 other identifier
observational
500
1 country
1
Brief Summary
A multicenter observational study designed specifically to collect data on the safety of sport activities in patients with implanted S-ICD systems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2023
CompletedFirst Submitted
Initial submission to the registry
February 11, 2023
CompletedFirst Posted
Study publicly available on registry
March 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2029
ExpectedMarch 3, 2023
February 1, 2023
2.9 years
February 11, 2023
February 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Tachyarrhythmia-related death or externally resuscitated cardiac arrest due to S-ICD
Quantitative data will be reported by S-ICD interrogation including shock failure, incessant ventricular arrhythmia, or post-shock pulseless electrical activity.
5 years
Secondary Outcomes (1)
S-ICD Lead fracture/malfunction
5 years
Study Arms (1)
study population
The study population will consist of patients with an implanted S-ICD as their first implanted device, who continue to exercise regularly and actively participate in competitive or recreational sports with a sport-intensity above a predefined level
Interventions
Eligibility Criteria
patients with an implanted S-ICD as their first implanted device, who continue to exercise regularly and actively participate in competitive or recreational sports with a sport-intensity above a predefined level
You may qualify if:
- Patient (male or female) is \<60 years of age.
- Patient has an implanted with a new-generation S-ICD \[Boston Scientific EMBLEM, Generations 2 (model A209), 3 (A219) or newer\].
- Present device is the first defibrillator implanted.
- Patient has a functioning LATITUDE™ Home-Monitoring-System at home, knows how to use it and sends weekly reports via the home-monitoring system.
- Patient actively participates in sport activities above a predefined level of exercise (see below).
- Patient understands that, at present, there is virtually no data on the safety of sport participation for patients with implanted S-ICD system, particularly regarding potential damage caused by sport activities to the S-ICD system, including the subcutaneous electrode.
- Patient understands that the level of sport activity, type of sport and frequency of exercise activities are entirely at his/her own discretion and responsibility.
- Patient understands that The Sport S-ICD Study investigator neither encourage nor discourage performance of any given sport.
- Patient understands that The Sport S-ICD Study is not liable for- and does assume any responsibility for any damages caused by sport participation to the implanted system or the health of patients participating in the study.
- Patient is willing to provide informed consent to participate in the SPORT S-ICD Study. Informed consent includes agreement to provide all the following information:
- Clinical data (age, gender, clinical diagnosis, indication for S-ICD implantation, arrhythmic events since S-ICD implantation, adverse events since S-ICD implantation)
- Information concerning endpoint events during follow-up.
You may not qualify if:
- Subjects with an inability to communicate well with the investigators.
- Subjects who are non-cooperative or unwilling to sign consent form.
- Evidence suggestive of malfunction of the implanted S-ICD system (like abnormal impedance or detected noise) at the time of screening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Eli Sprecher, MDlead
Study Sites (1)
Tel Aviv Medical Center
Tel Aviv, Israel
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Deputy director general for R&D
Study Record Dates
First Submitted
February 11, 2023
First Posted
March 3, 2023
Study Start
February 1, 2023
Primary Completion
January 1, 2026
Study Completion (Estimated)
January 1, 2029
Last Updated
March 3, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share